dihexa renal toxicity AngIV-Analog Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway Could One Compound Help the

doi: 10.1186/s12875-024-02540-z

One key factor in evaluating clinical translation is determining the optimal dose and safety of that specific therapy

Ethics declarations Conflict of interest The authors declare that there are no conflicts of interest

Some researchers wrap vials in aluminum foil for extra light protection

So they're never gonna let it come to the market because it's going to be, you know, it's gonna keep people from getting surgeries and then big pharma is not gonna make money and all that

Specifically, he said that the FDA plans remove about 14 peptides from the list of bulk ingredients that cannot be prepared by a compounding pharmacy